겸상 적혈구 빈혈 검사 및 스크리닝 시장 : 검사 방법별, 연령대별, 부문별, 지역별

The global sickle cell anemia testing and screening market is estimated to be valued at USD 465.2 Mn in 2024 and is expected to reach USD 1,028.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 12% from 2024 to 2031.

Figure. Sickle Cell Anemia Testing and Screening Market Share (%), By Region 2024

Sickle cell anemia is a genetic blood disorder that affects the red blood cells and causes them to take on a C-like or sickle shape. It is a group of disorders that causes the red blood cells to become misshapen and break down leasing to anemia. The disorder is more common in those with ancestry from sub-Saharan Africa, Latin America, Central America, and India. With increased immigration and travel globally, its prevalence has increased in diverse populations as well. Early screening programs can help in the management of the condition and prevent complications through lifelong treatment and monitoring.

Market Dynamics:

The global sickle cell anemia testing and screening market is driven by the increasing prevalence of the genetic blood disorder globally. In October 2021, as per the World Health Organization (WHO), it is estimated that over 300,000 children are born with sickle cell anemia each year. Growing awareness among at-risk populations and incorporating screening in prenatal testing are providing lucrative opportunities in the market. However, lower adoption and awareness levels in developing regions continues to restrain the market growth. Developments in precision medicine and non-invasive testing techniques can help overcome challenges and further expand the market reach during the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global sickle cell anemia testing and screening market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global sickle cell anemia testing and screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Agios Pharmaceuticals, Inc., Bluebird bio, Inc., PerkinElmer, Inc., Laboratory Corporation of America Holdings, Global Blood Therapeutics, Inc., Edvotek Inc., Maternova Inc., Hemex Health, CRISPR Therapeutics, Anamol Laboratories Pvt. Ltd., Atlas Medical GmbH, and Calibre Scientific, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global sickle cell anemia testing and screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sickle cell anemia testing and screening market

Market Segmentation

• By Testing Method Insights (Revenue, USD Mn, 2019 - 2031)
  • Hemoglobin Electrophoresis
  • High-Performance Liquid Chromatography (HPLC)
  • Point-of-Care Tests
  • Genetic Testing
  • Others
• By Age Group Insights (Revenue, USD Mn, 2019 - 2031)
  • Newborn Screening
  • Ages 1 to 25
  • Ages 26 and Above
• By Sector Insights (Revenue, USD Mn, 2019 - 2031)
  • Government Labs
  • Private Labs
  • Corporate Labs
  • PPP (Public Private Partnerships)
• Regional Insights (Revenue, USD Mn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Quest Diagnostics Incorporated
  • Agios Pharmaceuticals, Inc.
  • Bluebird bio, Inc.
  • PerkinElmer, Inc.
  • Laboratory Corporation of America Holdings
  • Global Blood Therapeutics, Inc.
  • Edvotek Inc.
  • Maternova Inc.
  • Hemex Health
  • CRISPR Therapeutics
  • Anamol Laboratories Pvt. Ltd.
  • Atlas Medical GmbH
  • Calibre Scientific, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Sickle Cell Anemia Testing and Screening Market, By Testing Method
  • Global Sickle Cell Anemia Testing and Screening Market, By Age Group
  • Global Sickle Cell Anemia Testing and Screening Market, By Sector
  • Global Sickle Cell Anemia Testing and Screening Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Sickle Cell Anemia Testing and Screening Market, By Testing Method, 2019-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hemoglobin Electrophoresis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• High-Performance Liquid Chromatography (HPLC)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Point-of-Care Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Genetic Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global Sickle Cell Anemia Testing and Screening Market, By Age Group, 2019-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Newborn Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Ages 1 to 25
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Ages 26 and Above
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Sickle Cell Anemia Testing and Screening Market, By Sector, 2019-2031, (USD Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Government Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Private Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Corporate Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
• Public Private Partnerships (PPP)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Sickle Cell Anemia Testing and Screening Market, By Region, 2019 - 2031, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Testing Method, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Age Group, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Sector, 2019 - 2031, Value (USD Mn)
  • Market Size and Forecast, By Country /Region, 2019 - 2031, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Bio-Rad Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quest Diagnostics Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agios Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bluebird bio, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PerkinElmer, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Laboratory Corporation of America Holdings
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Global Blood Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Edvotek Inc.
• Maternova Inc.
• Hemex Health
• CRISPR Therapeutics
• Anamol Laboratories Pvt. Ltd.
• Atlas Medical GmbH
• Calibre Scientific, Inc.

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us